The Wallach RevolutionThe Citizens Committee for Better Medicine is proud to present “The Wallach Revolution – (An Unauthorized Biography of a Medical Genius)”. The book is now available and chronicles the challenges, successes, and unique perspective of Dr. Joel D Wallach, a true pioneer in the field of science-based, clinically verified medical nutrition. (No portion of the content on this site may be exhibited, used or reproduced by any means without express written permission of the publisher.) Click HERE to get your copy of this brand new book!
Thanks to the overwhelming weight of court victories against FDA on speech grounds, FDA now has in place a qualified health claims review process. Although FDA continues to censor nutrient-disease information, and Wallach’s battle against speech suppression continues, there is now a clear way to get claims reviewed by FDA and challenged in federal courts under the First Amendment when the agencies refused to permit them despite credible supporting evidence.
Due to his unceasing efforts to end FDA censorship of truthful and non-misleading nutrient-disease relationship claims, the constitutional and administrative law firm Emord & Associates, P.C. awarded Dr. Wallach its “First Amendment Hall of Fame Award” in 2014.
Chapter 16 Page 3
Wallach Defeats FDA Censorship
Wallach also sued the FDA in cases that produced precedent victories over the agency, among them: Whitaker v. Thompson (2002); Alliance for Natural Health US v. Sebelius (2011); and Alliance for Natural Health US v. Sebelius II (2012). He also filed suit as an intervenor in Center for Science in the Public Interest v. FDA (2010) to protect qualified health claims from a decision CSPI sought which would have re-established suppression of them as the order of the day. Wallach won that suit as well.
Those cases secured from FDA censorship claims that antioxidant vitamins reduced the risk of certain kinds of cancers; that selenium reduced the risk of certain cancers; and that omega-3 fatty acids reduced the risk of coronary heart disease.
Those decisions forced FDA to allow nutrient-disease claims into the market by compelling FDA to avoid censorship in favor of claim qualification. They also made FDA use succinct and accurate qualifications free of value laden bias.